Increased insulin production and secretion from beta cells and inhibition of GCG release from alpha cells in the pancreas are the primary effects of GLP-1 acting via certain GLP-1 receptors found on certain bodily tissues, including the pancreas.
Glucagon-like peptide-1 (GLP-1) was discovered as an incretin hormone, which is released from the intestine upon nutrient intake and stimulates insulin secretion from the pancreatic islet -cells. Subsequently, its ability to suppress appetite was recognized.
GLP-1 influences key secretagogues and intracellular mediators (calcium, glutamate, -aminobutyric acid, serotonin, and urocortin-3), with complex roles in insulin exocytosis. Additionally, we discuss the interplay between calcium and cAMP, and how GLP-1 modulates both pathways to coordinate insulin secretion.
Such details provide a deeper understanding and appreciation for Role Of Glp-1 In Regulating Insulin Secretion.
Glucagon-like peptide 1 (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIPR) receptors are involved in glucose homeostasis. Zamia et al. show that -arrestin 2 (ARRB2) plays distinct roles in regulating GLP-1R/GIPR signaling. GIP-potentiated insulin secretion and ERK/CREB activation induced by pharmacological doses of GLP-1 require ARRB2. By contrast, ARRB2 dampens insulin ...
Such details provide a deeper understanding and appreciation for Role Of Glp-1 In Regulating Insulin Secretion.
bstract Gastrointestinal hormones that potentiate insulin secretion from pancreatic -cells are called incretins. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the major incretins.
